Freestone Capital Holdings’s Harte-Hanks HHS Stock Holding History

Freestone Capital Holdings’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$412	–	1299
2020 Q3	$412	Buy	+200	New	+$573	﹤0.01%	1179

Other funds holding HHS

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Freestone Capital Holdings's HHS Position: Q4 2020 in Review

Freestone Capital Holdings sold out of Harte-Hanks (HHS) in Q4 2020, closing a stake of 200 shares — an estimated $412 sold.

Freestone Capital Holdings first reported a position in HHS in Q3 2020 and held it in 1 quarter. The position peaked at $412 in Q3 2020. 1 fund tracked by Wall St. Rank holds HHS as of Q4 2020.

Freestone Capital Holdings reported no remaining Harte-Hanks position as of Q4 2020 after selling out during the quarter.
Freestone Capital Holdings sold 200 Harte-Hanks shares in Q4 2020, an estimated $412.
Freestone Capital Holdings first reported a position in Harte-Hanks in Q3 2020 and held it in 1 quarter.
Freestone Capital Holdings's Harte-Hanks position peaked at $412 in Q3 2020.
1 fund tracked by Wall St. Rank held Harte-Hanks as of Q4 2020.

Based on Freestone Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.